BPC-157 Stability: How It Degrades and How to Slow It

BPC-157 is one of the more stable research peptides because its sequence has no methionine, cysteine, tryptophan, histidine, asparagine or glutamine. Its main slow degradation route is hydrolysis of the bond between its two aspartic acids at positions 10 and 11, which cold storage, a near-neutral pH and keeping the powder dry all slow down.

Why the sequence is so stable

The sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. BPC-157 was identified in human gastric juice, and its developers report it stays native there for more than 24 hours, where acid and pepsin break most peptides down quickly (Sikiric et al., Current Pharmaceutical Design, 2011; Sikiric et al., Pharmaceuticals, 2025).

A 2026 biopharmaceutical review walked through the sequence residue by residue (Mateescu et al., Pharmaceutics, 2026). Its points, and what they mean for a research vial:

• No oxidation-prone residues. With no methionine, cysteine, tryptophan or histidine, there is nothing for dissolved oxygen or light-generated radicals to attack readily.
• No deamidation. There is no asparagine or glutamine, so the Asn-Gly deamidation that slowly converts many peptides in solution cannot happen.
• No pyroglutamate. The N-terminus is glycine, not glutamine or glutamic acid, so the N-terminal cyclisation seen in some peptides is not a route here; the glutamic acid sits at position 2.
• Proline-rich backbone. Four prolines, three of them consecutive at positions 3 to 5, disfavour the beta-sheet stacking that drives aggregation and gelling.
• One reactive amine. Lysine 7 can react with reducing sugars (glycation). Bacteriostatic water contains no sugar, so this matters for formulation work rather than a mixed research vial.

The Asp-Asp bond: the slow route

The review identifies hydrolysis at Asp10 to Asp11 as BPC-157’s primary chemical liability under acidic and neutral conditions (Mateescu et al., Pharmaceutics, 2026). Aspartic acid side chains can attack their own neighbouring peptide bond, either cutting the chain or passing through a five-membered succinimide ring that reopens as the isoaspartate form (Geiger and Clarke, Journal of Biological Chemistry, 1987). This happens fastest at Asp-Gly and Asp-Pro bonds; BPC-157 has neither, since its aspartates are followed by aspartate and alanine, which is part of why the rate is slow.

Warmth and acid are what move this bond, which is why a reconstituted vial lives in the fridge in near-neutral bacteriostatic water: at 2 to 8 °C the same chemistry runs very slowly.

Lyophilised versus reconstituted

A sealed lyophilised vial holds a dry cake with almost no water, so hydrolysis has very little to work with. In accelerated testing, solid BPC-157 held for 90 days at 50 °C and 65% relative humidity, a harsh accelerated condition, still retained most of its content (Rucman, US Patent 9,850,282, 2017). In practice sealed powder keeps for the weeks a vial is in use at 2 to 8 °C and for months at minus 20 °C, and days at room temperature in transit do not harm it.

Once mixed, water is present and the Asp-Asp clock starts. Under our handling guidance a vial mixed with bacteriostatic water lasts 8 to 12 weeks at 2 to 8 °C, with quality slowly fading from around week 6 to 8. No formal long-term solution stability study for BPC-157 has been published, so that window is general guidance that its chemistry supports. The full table is on how long BPC-157 lasts.

Temperature

Hydrolysis roughly doubles to triples in rate for every 10 °C rise, a general rule of peptide chemistry that applies to the Asp-Asp bond like any other. That is why a mixed vial goes straight back into the main body of the fridge after each access and is not left on the bench.

Light

BPC-157 has no tryptophan, tyrosine or phenylalanine, the aromatic residues that absorb ultraviolet light and start photo-oxidation, so it is less light-sensitive than most peptides. Keeping the vial boxed in the dark remains standard practice.

Freeze-thaw

Sealed powder can be frozen. A mixed vial that will be opened again is not, because ice formation concentrates peptide and salts at the crystal boundaries and repeated cycles promote aggregation (Manning et al., Pharmaceutical Research, 2010). The proline-rich backbone resists this better than most, but the rule is general: laboratories that need frozen solution split it into single-use aliquots and thaw each once.

pH

Because acid accelerates the Asp-Asp bond, BPC-157 is not dissolved in acetic acid. Plain bacteriostatic water is the right solvent; see the BPC-157 solubility guide for why.

What visible changes mean

Mixed BPC-157 is clear and colourless. Because its main degradation products are also clear, a clear vial is not on its own proof of full strength; the mixing date and storage history matter as much as the look. Discard the solution if it shows:

• Cloudiness that does not clear within 10 to 15 minutes of mixing.
• Strands, flakes or particles.
• Any yellow or other tint.
• A history of being frozen and thawed, or left out overnight.

The general causes of haze and gel are covered in why peptides gel or go cloudy. Bench steps that protect stability are on the BPC-157 handling page.